Sign In
Buy STVN
$19.85
-0.350 (-1.73%)
At Close: Jul 31, 2026
Stevanato Group S.p.A. (STVN) Q4 2024 Earnings Call Transcript
12:33pm, Thursday, 06'th Mar 2025
Stevanato Group S.p.A. (NYSE:STVN ) Q4 2024 Earnings Conference Call March 6, 2025 8:30 AM ET Company Participants Lisa Miles - SVP, IR Franco Stevanato - Chairman and CEO Marco Dal Lago - CFO Confere
Stevanato Group (STVN) Meets Q4 Earnings Estimates
08:45am, Thursday, 06'th Mar 2025
Stevanato Group (STVN) came out with quarterly earnings of $0.20 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.19 per share a year ago.
Stevanato Group Reports Record Revenue of €1,104 Million for Fiscal Year 2024
06:31am, Thursday, 06'th Mar 2025
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology,
Stevanato Group to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 6, 2025
04:02pm, Monday, 24'th Feb 2025
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology
USNA or STVN: Which Is the Better Value Stock Right Now?
12:46pm, Friday, 14'th Feb 2025
Investors interested in Medical - Drugs stocks are likely familiar with USANA Health Sciences (USNA) and Stevanato Group (STVN). But which of these two stocks presents investors with the better value
USNA vs. STVN: Which Stock Is the Better Value Option?
12:40pm, Wednesday, 29'th Jan 2025
Investors looking for stocks in the Medical - Drugs sector might want to consider either USANA Health Sciences (USNA) or Stevanato Group (STVN). But which of these two stocks offers value investors a
UTHR vs. STVN: Which Stock Is the Better Value Option?
12:55pm, Wednesday, 08'th Jan 2025
Investors interested in stocks from the Medical - Drugs sector have probably already heard of United Therapeutics (UTHR) and Stevanato Group (STVN). But which of these two stocks is more attractive to
Stevanato Group to Present at Upcoming Investor Conference
04:30pm, Tuesday, 07'th Jan 2025
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life sciences
Stevanato: Supportive Biopharmaceutical And Diagnostic Segment And Destocking Improvement
01:18am, Wednesday, 13'th Nov 2024
Q3 2024 sales exceeded estimates, but adj. EBITDA and EPS fell short due to under-utilization and higher costs in the Engineering division. Despite temporary headwinds, we expect sequential margin imp
Stevanato Group to Present at Upcoming Investor Conferences
06:32am, Monday, 11'th Nov 2024
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life sciences
CPRX vs. STVN: Which Stock Is the Better Value Option?
12:45pm, Wednesday, 06'th Nov 2024
Investors with an interest in Medical - Drugs stocks have likely encountered both Catalyst Pharmaceutical (CPRX) and Stevanato Group (STVN). But which of these two companies is the best option for tho
Stevanato Group S.p.A. (STVN) Q3 2024 Earnings Call Transcript
02:10pm, Tuesday, 05'th Nov 2024
Stevanato Group S.p.A. (NYSE:STVN ) Q3 2024 Earnings Conference Call November 5, 2024 8:30 AM ET Company Participants Lisa Miles - Senior Vice President & Investor Relations Franco Stevanato - Chairma
Stevanato Group (STVN) Q3 Earnings Match Estimates
08:51am, Tuesday, 05'th Nov 2024
Stevanato Group (STVN) came out with quarterly earnings of $0.13 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.16 per share a year ago.
Stevanato Group to Report Third Quarter 2024 Financial Results on November 5, 2024
04:30pm, Tuesday, 22'nd Oct 2024
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology a
Stevanato Group to Report Third Quarter 2024 Financial Results on November 5, 2024
04:30pm, Tuesday, 22'nd Oct 2024
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology a
